Profile
Peter Bluford joined BioSeek, Inc. as Vice President of Business Development in January, 2006.
Prior to joining BioSeek he was Vice President of Corporate Development for Sangamo BioSciences, Inc. from 1996 to 2004 and he held various positions at Somatix Therapy Corp.
from 1992 to 1996.
He was Director of Commercial Development for Somatix Therapy from 1992 to 1995 and Project Team Leader of the GVAX cancer vaccine program from 1995 to 1996.
He was Manager of Strategic Market Planning for Celtrix Pharmaceuticals, Inc. and BioGrowth, Inc. from 1990 to 1992, an Associate Product Manager of Clontech, Inc. from 1988 to 1989 and Research Associate of Triton Biosciences from 1987 to 1988.
Mr. Bluford received a BS degree in Biochemistry and an MBA from the University of California, Berkeley.
Former positions of Peter Bluford
| Companies | Position | End |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2004 |
Somatix Therapy Corp.
 Somatix Therapy Corp. BiotechnologyHealth Technology Somatix Therapy Corp. researches, develops, and commercialize proprietary processes for the genetic modification of cells and their use in the treatment of human disease. Somatix's assets include its highly efficient gene transfer technology, broad-based intellectual property, and focused product development programs. The company's most advanced clinical development program, the GVAX cancer vaccine, is in Phase I/II clinical trials for the treatment of metastatic renal cell carcinoma, advanced melanoma, and prostate cancer. It is located in Alameda, CA | Corporate Officer/Principal | 01/01/1996 |
Celtrix Pharmaceuticals, Inc.
 Celtrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Insmed, Inc., Celtrix Pharmaceuticals, Inc. researches and develops potential therapeutic products. The company is based in Santa Clara, CA. | Corporate Officer/Principal | 02/01/1992 |
| BioGrowth, Inc. | Corporate Officer/Principal | 01/01/1992 |
Takara Bio USA, Inc.
 Takara Bio USA, Inc. Medical/Nursing ServicesHealth Services Takara Bio USA, Inc. helps to accelerate the discovery process by providing pioneering tools that enable researchers to ask new questions and investigate ever more complex systems than was previously possible. With more than 5,000 literature citations, its innovative products and services continue to facilitate advancement in areas such as genomics, cancer research, apoptosis, cytogenetics, developmental genetics, cellular physiology, pharmocogenetics, and neurobiology. | Corporate Officer/Principal | 01/01/1989 |
Training of Peter Bluford
| University of California, Berkeley | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Celtrix Pharmaceuticals, Inc.
Celtrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Insmed, Inc., Celtrix Pharmaceuticals, Inc. researches and develops potential therapeutic products. The company is based in Santa Clara, CA. | Health Technology |
Somatix Therapy Corp.
Somatix Therapy Corp. BiotechnologyHealth Technology Somatix Therapy Corp. researches, develops, and commercialize proprietary processes for the genetic modification of cells and their use in the treatment of human disease. Somatix's assets include its highly efficient gene transfer technology, broad-based intellectual property, and focused product development programs. The company's most advanced clinical development program, the GVAX cancer vaccine, is in Phase I/II clinical trials for the treatment of metastatic renal cell carcinoma, advanced melanoma, and prostate cancer. It is located in Alameda, CA | Health Technology |
Takara Bio USA, Inc.
Takara Bio USA, Inc. Medical/Nursing ServicesHealth Services Takara Bio USA, Inc. helps to accelerate the discovery process by providing pioneering tools that enable researchers to ask new questions and investigate ever more complex systems than was previously possible. With more than 5,000 literature citations, its innovative products and services continue to facilitate advancement in areas such as genomics, cancer research, apoptosis, cytogenetics, developmental genetics, cellular physiology, pharmocogenetics, and neurobiology. | Health Services |
| Triton BioSystems, Inc. | Health Technology |
| BioGrowth, Inc. |
- Stock Market
- Insiders
- Peter Bluford
